nder pressure from the White House, Big Pharma has been touting “discounts” via Direct to Consumer (DTC) websites. Meanwhile, the Trump administration promises to unveil its own prescription website, immodestly named TrumpRx, in 2026. Prescription drug prices obviously are still too high, though President Biden’s Inflation Reduction Act (IRA) of 2022 was beginning to make headway in bringing them down. Unlike Biden’s IRA, these latest gestures by Big Pharma and the Trump Administration should be viewed with a healthy dose of skepticism.